Virax Biolabs Group Limited

Healthcare · Biotechnology · United Kingdom

Last price 1.21 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 964.36K

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It also provides ImmuneSelect, a research-use-only p...